HOME >> MEDICINE >> NEWS
Scripps research combination therapy obliterates new vessel growth in tumors and retinopathy

e use of lower doses of angiostatic therapies could minimize potential adverse side effects.

"The point of the study was to show proof-of-concept that targeting multiple angiogenic pathways will be more effective than inhibiting single ones due to potential compensatory upregulation," Friedlander said. "As more and more anti-angiogenic agents reach the market, there will be even more combinations to choose from. In our laboratory, we're now looking at new combinations of approved angiostatic drugs to see if we can achieve similar promising results that can have immediate translation into the clinic."


'"/>

Contact: Marisela Chevez
mchevez@scripps.edu
858-784-2171
Scripps Research Institute
9-Jan-2007


Page: 1 2 3

Related medicine news :

1. Scripps Research awarded $17 million for adult stem cell use to treat eye diseases
2. Synthetic production of potential pharmaceuticals dramatically simplified by Scripps research team
3. The Scripps Research Institute, McDonalds align to fight childhood obesity and type 2 diabetes
4. Scripps research team reverses Friedreichs ataxia defect in cell culture
5. Scripps research scientists test anti-obesity vaccine
6. 1 of 2 pediatric kidney disease research centers in world established
7. Stanford researchers find culprit in aging muscles that heal poorly
8. UCLA researchers awarded $9M contract for study identifiying antibiotic treatment for MRSA
9. Indiana University Imaging Center receives $6M grant for kidney research
10. Penn researchers discover novel pathway for increasing good cholesterol
11. New research discovers independent brain networks control human walking

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/30/2017)... ... April 30, 2017 , ... PracticeMatch, a company that provides healthcare recruiting resources ... year’s physician career fairs, with this year’s RSVPs and registrations so far tracking a ... year of national physician career fairs is located on the PracticeMatch website. ...
(Date:4/29/2017)... , ... April 29, 2017 , ... TransDark is a ... from one video to the next without having to set a single keyframe in ... transitions to enhance your video production. , TransDark features dynamic transitions that momentarily splits ...
(Date:4/29/2017)... ... 2017 , ... Saturday, April 29, marks World Veterinary Day, ... on animal health and welfare as well as on public health. The World ... theme each year and this year have selected “Antimicrobial Resistance—From Awareness to Action,” ...
(Date:4/28/2017)... NY (PRWEB) , ... April 28, 2017 , ... It's ... there are a number of illnesses that are unclear as to whether or not ... their heads. Bronchitis is one of these illnesses. So, FindaTopDoc took a look into ...
(Date:4/28/2017)... LINCOLN, R.I. (PRWEB) , ... April 28, 2017 , ... Getting enough sleep affects much ... Sleep Foundation (NSF), going just 19 hours without sleep can compromise motor reaction time, which ... Awareness Week, and Amica Insurance is sharing the following tips from the NSF to help ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)...   ZappRx, Inc ., a digital health company focused ... announced it closed $25 million in Series B funding led ... in Seattle that is part of ... Series B round included participation from SR One , ... GV (formerly Google Ventures). As part of the financing, ...
(Date:4/20/2017)... DUBLIN , April 20, 2017 ... "Global Pharmacogenomics Market Size, Market Share, Application Analysis, Regional Outlook, ... 2024" report to their offering. ... The global pharmacogenomics market was valued at US$ ... 11,938.8 Mn by 2024, expanding at a CAGR of 5.6% ...
(Date:4/20/2017)... , April 20, 2017 NeuroVive Pharmaceutical ... today announced positive preclinical results demonstrating anti-fibrotic ... for non-alcoholic steatohepatitis (NASH), in an additional ... NV556 has previously shown similar anti-fibrotic ... Today, NeuroVive,s scientists present novel data demonstrating ...
Breaking Medicine Technology:
Cached News: